Data Sources - The DataCity, Crunchbase, Tech Nation, Linkedin
Global Leader in Artificial Intelligence
The UK’s AI market is estimated to grow significantly during the next 5 years and to add £625bn to the UK economy by 2035. UK VC investment has reached record highs with the Cambridgeshire and Peterborough region home to many of the fastest growing scale ups as well as larger tech company’s R&D centres. Due to the AI talent pool, support networks and connected investor community, the Cambridgeshire and Peterborough region has become world renowned as a centre for excellence across all aspects of AI, including machine learning, robotics and artificial neural networks.
High Growth eco-system
The Artificial Intelligence (AI) market is dynamic and any market success will depend on how closely business is linked with world class talent. Some of the sharpest minds in AI graduate from the University of Cambridge and Anglia Ruskin University. Both are particularly strong in areas like computing and mathematics, essential for pioneering research in AI.
World Class Networks
An active community of over 1000 technology companies ranging from major network operators and device manufacturers to innovative start-ups and universities. They stimulate debate and collaboration, harnesses and share knowledge, and help to build connections between academia and industry. They run specialist events and programmes on AI including the Specialist Interest Group on AI.Find out more
Leverhulme Centre for the Future of Intelligence
Their mission is to build a new interdisciplinary community of researchers, with strong links to technologists and the policy world, and a clear practical goal: to work together to ensure that humans make the best of the opportunities of artificial intelligence as it develops over coming decades.Find out more
Cambridge Centre for AI in Medicine
Bridging the gap between the complex fields of AI, bioscience and medicine requires deep interdisciplinary collaboration. The Cambridge Centre for AI in Medicine, funded by industry partners AstraZeneca and GSK,is helping to make this a reality through its-world-leading research, close partnerships with the NHS and industry, and a range of education initiatives.Find out more